Technical Analysis for HRTX - Heron Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 18.08 | -0.44% | -0.08 |
Earnings due: May 4
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Historical HRTX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | -0.44% | |
| Overbought Stochastic | Strength | -0.44% | |
| Crossed Above 50 DMA | Bullish | 1.69% | |
| 180 Bullish Setup | Bullish Swing Setup | 1.69% | |
| Pocket Pivot | Bullish Swing Setup | 1.69% | |
| Overbought Stochastic | Strength | 1.69% | |
| Fell Below 50 DMA | Bearish | 5.42% | |
| Stochastic Sell Signal | Bearish | 5.42% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Possible NR7 | about 14 hours ago |
| 60 Minute Opening Range Breakout | about 16 hours ago |
| Rose Above Previous Day's High | about 19 hours ago |
| Up 1% | about 19 hours ago |
| Up 1% | 1 day ago |
Get this analysis on your stocks daily!
- Earnings date: 05/04/2021
Heron Therapeutics, Inc. Description
Heron Therapeutics, Inc., a specialty pharmaceutical company, develops product candidates using its proprietary Biochronomer polymer-based drug delivery platform. The company's drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that should be injected once or twice per day to products that need to be injected once every one or two weeks. Its lead product candidate, Sustol, is developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting for patients undergoing emetogenic chemotherapy. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Redwood City, California.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Clinical Medicine Pharmaceutical Oncology Cancer Treatments Chemotherapy Occupational Safety And Health Drug Delivery Antineoplastic Drugs Nausea
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 22.4 |
| 52 Week Low | 12.52 |
| Average Volume | 989,519 |
| 200-Day Moving Average | 16.97 |
| 50-Day Moving Average | 17.14 |
| 20-Day Moving Average | 16.77 |
| 10-Day Moving Average | 17.36 |
| Average True Range | 0.77 |
| ADX | 16.76 |
| +DI | 24.89 |
| -DI | 15.85 |
| Chandelier Exit (Long, 3 ATRs ) | 16.18 |
| Chandelier Exit (Short, 3 ATRs ) | 16.66 |
| Upper Bollinger Band | 18.63 |
| Lower Bollinger Band | 14.92 |
| Percent B (%b) | 0.85 |
| BandWidth | 22.15 |
| MACD Line | 0.32 |
| MACD Signal Line | 0.10 |
| MACD Histogram | 0.2172 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 18.79 | ||||
| Resistance 3 (R3) | 18.85 | 18.67 | 18.67 | ||
| Resistance 2 (R2) | 18.67 | 18.49 | 18.64 | 18.63 | |
| Resistance 1 (R1) | 18.38 | 18.38 | 18.29 | 18.32 | 18.59 |
| Pivot Point | 18.20 | 18.20 | 18.16 | 18.17 | 18.20 |
| Support 1 (S1) | 17.91 | 18.02 | 17.82 | 17.85 | 17.57 |
| Support 2 (S2) | 17.73 | 17.91 | 17.70 | 17.53 | |
| Support 3 (S3) | 17.44 | 17.73 | 17.49 | ||
| Support 4 (S4) | 17.38 |
